4.5 Review

Challenges in Management of VTE in Children With Cancer: Risk Factors and Treatment Options

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism The Kids-DOTT Randomized Clinical Trial

Neil A. Goldenberg et al.

Summary: Among patients younger than 21 years of age with provoked venous thromboembolism, 6-week anticoagulant therapy was noninferior to 3-month therapy in terms of recurrent venous thromboembolism risk and bleeding risk.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Hematology

Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C

Marie-Claude Pelland-Marcotte et al.

Summary: This study showed that cancer-associated thrombo-embolism (TE) during treatment significantly reduced overall survival (OS) and event-free survival (EFS) in children with acute lymphoblastic leukemia (ALL), particularly in those classified as high/very high-risk.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Review Oncology

The impact of the host intestinal microbiome on carcinogenesis and the response to chemotherapy

Jaime N. Wertman et al.

Summary: The microbiome, consisting of all microbes present on and within the human body, has been linked to diseases such as inflammatory bowel disease, diabetes, and certain types of cancer. Drug treatments can alter the composition of the intestinal microbiome, affecting the safety and efficacy of cancer treatments. Understanding the impact of the microbiome on cancer treatment can lead to improved outcomes.

FUTURE ONCOLOGY (2021)

Article Oncology

Gut bacterial gene changes following pegaspargase treatment in pediatric patients with acute lymphoblastic leukemia

Katherine A. Dunn et al.

Summary: Investigating stool samples from pediatric acute lymphoblastic leukemia patients treated with pegaspargase revealed a significant decline in asparagine, accompanied by changes in 31 microbial genes. These changes involve genes related to amino acid metabolism, nutrient sensing, and pathways associated with cancer.

LEUKEMIA & LYMPHOMA (2021)

Review Hematology

Venous Thromboembolism in Pediatric Cancer Patients with Central Venous Catheter-A Systematic Review and Meta-analysis

Rasmus Sogaard Hansen et al.

Summary: Pediatric cancer patients with central venous catheters face a significant risk of venous thromboembolism (VTE), especially those with acute lymphoblastic leukemia (ALL). Preferably, implantable port catheters should be used to reduce VTE risk in these patients, along with intensified catheter care.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)

Review Hematology

Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: A systematic review

Anjali A. Sharathkumar et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Review Hematology

The gut microbiome and thromboembolism

Rida Abid Hasan et al.

THROMBOSIS RESEARCH (2020)

Article Hematology

Cancer-associated thrombosis in pediatric patients

Assaf Arie Barg et al.

THROMBOSIS RESEARCH (2020)

Article Hematology

The Edoxaban Hokusai VTE PEDIATRICS Study: An open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease

Cornelia Heleen van Ommen et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Review Hematology

Direct oral anticoagulants: What will be their role in children?

Christoph Male et al.

THROMBOSIS RESEARCH (2019)

Review Pharmacology & Pharmacy

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia

Young-A Heo et al.

Article Hematology

Thromboembolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study

Marie-Claude Pelland-Marcotte et al.

THROMBOSIS AND HAEMOSTASIS (2018)

Review Oncology

Mechanisms and risk factors of thrombosis in cancer

Anna Falange et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Article Biochemistry & Molecular Biology

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

Weifei Zhu et al.

Review Pharmacology & Pharmacy

Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban

Wolfgang Mueck et al.

CLINICAL PHARMACOKINETICS (2014)

Article Education, Scientific Disciplines

Central venous catheter-related thrombosis

William Geerts

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)

Article Pediatrics

Port-A-Cath-Related Thrombosis and Postthrombotic Syndrome in Pediatric Oncology Patients

Manuela Albisetti et al.

JOURNAL OF PEDIATRICS (2013)

Article Clinical Neurology

Anticoagulants in Pediatric Cerebral Sinovenous Thrombosis A Safety and Outcome Study

Mahendranath D. Moharir et al.

ANNALS OF NEUROLOGY (2010)